Subclinical extrapyramidal symptoms caused by phenothiazine or butyrophenone derivatives can become manifest during and shortly after the consumption of alcohol. Alcohol appears to lower the threshold of resistance to neurotoxic side effects of previously established neuroleptic drugs. Abstinence from alcohol should be routine advice during neuroleptic psychopharmacotherapy.

Download full-text PDF

Source

Publication Analysis

Top Keywords

neuroleptic-induced akathisia
4
akathisia dystonia
4
dystonia triggered
4
alcohol
4
triggered alcohol
4
alcohol subclinical
4
subclinical extrapyramidal
4
extrapyramidal symptoms
4
symptoms caused
4
caused phenothiazine
4

Similar Publications

Restless legs syndrome, neuroleptic-induced akathisia, and the iron opioid dopamine link.

Sleep

March 2024

Professor of Neurology, Division of Sleep Medicine, Vanderbilt University School of Medicine, Medical Center North A-0118, Nashville, TN, USA.

View Article and Find Full Text PDF

Restlessness is a core symptom underlying restless legs syndrome (RLS), neuroleptic-induced akathisia, and opioid withdrawal. These three conditions also share other clinical components suggesting some overlap in their pathophysiology. Recent prospective studies demonstrate the frequent incidence of RLS-like symptoms during opioid withdrawal and supervised prescription opioid tapering.

View Article and Find Full Text PDF

Objective: Some lines of evidence show that D/D receptor partial agonist pramipexole may be effective in the treatment of extrapyramidal symptoms (EPS) and psychiatric symptoms of schizophrenia. Therefore, we analyzed whether a low dose of pramipexole (0.375-0.

View Article and Find Full Text PDF

Background And Objective: Akathisia is characterized by restlessness and crawling sensations similar to restless legs syndrome (RLS). Long latency flexor reflex (LLFR) which has helped to advance RLS pathophysiology has never been investigated in akathisia. Due to the clinical commonalities of akathisia and RLS, we investigated the behavior of LLFR in patients with akathisia aiming to understand pathophysiology of akathisia.

View Article and Find Full Text PDF

Clonidine Use in Psychiatry: Panacea or Panache.

Pharmacology

March 2017

Child and Adolescent Psychiatrist, KCMH, Shwaikh, Kuwait.

Clonidine, an alpha agonist, formally prescribed in clinical medicine as antihypertensive medication, is currently being used more frequently to address a multitude of psychiatric entities. The long-acting formulation is approved by the Food and Drug Administration for use in treating the attention-deficit/hyperactivity disorder. In addition to this only legitimate indication, it has long been used successfully for opiate detoxification, post-traumatic stress disorder and de la Tourette syndrome.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!